Senores Pharmaceuticals acquires ANDAs from Teva Pharmaceuticals USA - Indian Pharma Post
2025-08-13 • Google News
SENORES PHARMACEUTICALS L (SENORES)
NSEINR 686.50.39%
Price Chart
Key Statistics
Market Cap
INR 0
P/E Ratio
0.00
Revenue (TTM)
INR 0
Volume
175.68K
52W High
INR 751.20
52W Low
INR 435.25
Dividend Yield
0.00%
Beta
0.00
Technicals
50-Day MA
N/A
200-Day MA
N/A
52 Week High
751.2
52 Week Low
435.25
About SENORES
Senores Pharmaceuticals Limited develops, manufactures, sells, and trades in pharmaceutical and allied products in India, the United States, the United Kingdom, Canada, and internationally. The compan.
Employees
194
Headquarters
Ahmedabad, India
CEO
Mr. Swapnil Jatinbhai Shah
Latest News
Senores Pharmaceuticals Acquires ANDAs from Teva Using IPO Proceeds - geneonline.com
2025-08-13 • Google News
‘Estimados Señores’ Honors The Women Who Changed Colombia - The Loyola Phoenix
2025-04-16 • Google News
Top Gainers
Symbol/Name
LTP
% Chg
Top Losers
Symbol/Name
LTP
% Chg